✦ LIBER ✦

Su1141 Phase I Clinical Trial of the Combination Therapy Using Gemcitabine and GSK3beta Inhibiting Drugs for Gemcitabine-Resistant Advanced Pancreatic Cancer Patients

✍ Scribed by Shimasaki, Takeo; Ueda, Nobuhiko; Kawada, Natsuko; Nomura, Tomoe; Yamada, Kaho; Yamada, Hideto; Hayashi, Ranji; Matsunaga, Kazuhiro; Fukuyama, Tomoki; Otsuka, Toshimi; Nakamura, Masakatsu; Toshikuni, Nobuyuki; Shiroeda, Hisakazu; Kosaka, Takeo; Tomosugi, Naohisa; Minamoto, Toshinari; Arisawa, Tomiyasu

Book ID: 122180145
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 312 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)61389-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of gemcitabine and candesa

Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1

✍ Yousuke Nakai; Hiroyuki Isayama; Hideaki Ijichi; Takashi Sasaki; Hirofumi Kogure 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Phase I clinical trial using peptide vac

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

✍ Motoki Miyazawa; Ryuji Ohsawa; Takuya Tsunoda; Seiko Hirono; Manabu Kawai; Masaj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

A phase I trial of combination therapy u

A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer

✍ Eguchi, Hidetoshi; Nagano, Hiroaki; Kobayashi, Shogo; Kawamoto, Koichi; Wada, Hi 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 385 KB